Literature DB >> 7373317

Visual field abnormalities in multiple sclerosis.

V H Patterson, J R Heron.   

Abstract

Visual fields were examined with a tangent screen in 54 patients with multiple sclerosis (MS) or optic neuritis (ON). Visual fields were abnormal in all patients with definite MS, 94% with probable MS and 81% with possible MS. Three-quarters of the MS patients with no history of visual symptoms had abnormal fields. The commonest defect found was an arcuate scotoma. As a diagnostic test of visual pathway involvement in MS, tangent screen examination compares favourably with more sophisticated methods.

Entities:  

Mesh:

Year:  1980        PMID: 7373317      PMCID: PMC490511          DOI: 10.1136/jnnp.43.3.205

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

1.  Use of the Pulfrich pendulum for detecting abnormal delay in the visual pathway in multiple sclerosis.

Authors:  D Rushton
Journal:  Brain       Date:  1975-06       Impact factor: 13.501

2.  Visual evoked response in diagnosis of multiple sclerosis.

Authors:  A M Halliday; W I McDonald; J Mushin
Journal:  Br Med J       Date:  1973-12-15

3.  Differential diagnosis of the arcuate scotoma.

Authors:  D O Harrington
Journal:  Invest Ophthalmol       Date:  1969-02

4.  Grating test of contrast sensitivity in patients with retrobulbar neuritis.

Authors:  G B Arden; A G Gucukoglu
Journal:  Arch Ophthalmol       Date:  1978-09

5.  Pattern shift visual evoked responses. Two hundred patients with optic neuritis and/or multiple sclerosis.

Authors:  F Shahrokhi; K H Chiappa; R R Young
Journal:  Arch Neurol       Date:  1978-02

6.  Subclinical optic neuropathy in multiple sclerosis.

Authors:  R J Galvin; J R Heron; D Regan
Journal:  Arch Neurol       Date:  1977-11

7.  Ocular findings in the remission phase of multiple sclerosis.

Authors:  R W Zeller
Journal:  Am J Ophthalmol       Date:  1967-10       Impact factor: 5.258

8.  Subclinical optic neuropathy in multiple sclerosis. How early VER components reflect axon loss and conduction defects in optic pathways.

Authors:  M Feinsod; W F Hoyt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-11       Impact factor: 10.154

9.  Delayed visual perception and delayed visual evoked potentials in the spinal form of multiple sclerosis and in retrobulbar neuritis.

Authors:  D Regan; B A Milner; J R Heron
Journal:  Brain       Date:  1976-03       Impact factor: 13.501

10.  Quantitative perimetry in compressive optic neuropathy and optic neuritis.

Authors:  J D Trobe; J S Glaser
Journal:  Arch Ophthalmol       Date:  1978-07
View more
  8 in total

1.  Estimation of visual function after optic neuritis: a comparison of clinical tests.

Authors:  E A Sanders; A C Volkers; J C van der Poel; G H van Lith
Journal:  Br J Ophthalmol       Date:  1986-12       Impact factor: 4.638

2.  Visual function and pattern visual evoked response in optic neuritis.

Authors:  E A Sanders; A C Volkers; J C van der Poel; G H van Lith
Journal:  Br J Ophthalmol       Date:  1987-08       Impact factor: 4.638

3.  Foveal interocular time thresholds and latency differences in multiple sclerosis.

Authors:  W H Ehrenstein; K Manny; G Oepen
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

4.  Bilateral homonymous visual field defects as initial manifestation of multiple sclerosis.

Authors:  B Sanchez-Dalmau; F J Goñi; M Guarro; C Roig; F Duch-Bordas
Journal:  Br J Ophthalmol       Date:  1991-03       Impact factor: 4.638

5.  The Farnsworth-Munsell 100 hue test in the first episode of demyelinating optic neuritis.

Authors:  M J Ménage; D Papakostopoulos; J C Dean Hart; S Papakostopoulos; Y Gogolitsyn
Journal:  Br J Ophthalmol       Date:  1993-02       Impact factor: 4.638

6.  Subclinical visual field defects in multiple sclerosis. Demonstration and quantification with automated perimetry, and comparison with visually evoked potentials.

Authors:  O Mienberg; J Flammer; H P Ludin
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

7.  Ocular flutter in suspected multiple sclerosis: a presenting paroxysmal manifestation.

Authors:  D A Francis; J R Heron
Journal:  Postgrad Med J       Date:  1985-04       Impact factor: 2.401

Review 8.  Glatiramer acetate in treatment of multiple sclerosis: a toolbox of random co-polymers for targeting inflammatory mechanisms of both the innate and adaptive immune system?

Authors:  Babak Jalilian; Halldór Bjarki Einarsson; Thomas Vorup-Jensen
Journal:  Int J Mol Sci       Date:  2012-11-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.